1. Home
  2. MXCT vs UIS Comparison

MXCT vs UIS Comparison

Compare MXCT & UIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • UIS
  • Stock Information
  • Founded
  • MXCT 1999
  • UIS 1942
  • Country
  • MXCT United States
  • UIS United States
  • Employees
  • MXCT N/A
  • UIS N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • UIS EDP Services
  • Sector
  • MXCT Health Care
  • UIS Technology
  • Exchange
  • MXCT Nasdaq
  • UIS Nasdaq
  • Market Cap
  • MXCT 239.2M
  • UIS 271.5M
  • IPO Year
  • MXCT 2021
  • UIS N/A
  • Fundamental
  • Price
  • MXCT $2.15
  • UIS $4.43
  • Analyst Decision
  • MXCT Strong Buy
  • UIS Hold
  • Analyst Count
  • MXCT 1
  • UIS 1
  • Target Price
  • MXCT $9.00
  • UIS $6.50
  • AVG Volume (30 Days)
  • MXCT 1.3M
  • UIS 707.6K
  • Earning Date
  • MXCT 08-05-2025
  • UIS 08-04-2025
  • Dividend Yield
  • MXCT N/A
  • UIS N/A
  • EPS Growth
  • MXCT N/A
  • UIS N/A
  • EPS
  • MXCT N/A
  • UIS N/A
  • Revenue
  • MXCT $37,675,000.00
  • UIS $1,952,700,000.00
  • Revenue This Year
  • MXCT $8.82
  • UIS N/A
  • Revenue Next Year
  • MXCT $21.12
  • UIS $3.79
  • P/E Ratio
  • MXCT N/A
  • UIS N/A
  • Revenue Growth
  • MXCT N/A
  • UIS N/A
  • 52 Week Low
  • MXCT $2.10
  • UIS $3.32
  • 52 Week High
  • MXCT $5.26
  • UIS $8.93
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 39.58
  • UIS 40.93
  • Support Level
  • MXCT $2.20
  • UIS $4.75
  • Resistance Level
  • MXCT $2.40
  • UIS $4.98
  • Average True Range (ATR)
  • MXCT 0.13
  • UIS 0.17
  • MACD
  • MXCT 0.02
  • UIS -0.10
  • Stochastic Oscillator
  • MXCT 7.41
  • UIS 2.59

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About UIS Unisys Corporation New

Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides workplace solutions featuring intelligent workplace services, proactive experience management and collaboration tools to support business growth. CA&I which provides digital transformation in the areas of cloud migration and management. ECS which provides solutions that harness secure, high-intensity enterprise computing and enable digital services through software-defined operating environments. Majority of revenue is from ECS segment.

Share on Social Networks: